Yeah they also said this just a couple of weeks ago too...
"Prudent capital management on display again from ResApp who haven’t stuffed around with running multiple clinical programs cost effectively.
$3.4M in cash (plus R&D rebate) will comfortably take us past pivotal results over the next few quarters. Looking forward to enrolment completion and successful results."
No offence to RNClarke but at the end of the day we are all just speculating. No need to for anyone to appologise to anyone. and defs no need for a new thread just for it. Who knows the reason behind the Cap raise (only Rap at the mo) all will be clear soon enough. Just hang tight and lets get back to interesting discussion about the business.
RAP Price at posting:
27.0¢ Sentiment: Hold Disclosure: Held
